Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis

17 Jan 2012

Abstract excerpt

BACKGROUND: The complex pathogenesis of multiple sclerosis, combined with an unpredictable prognosis, requires identification of disease-specific diagnostic and prognostic biomarkers. OBJECTIVE: To determine whether inflammatory proteins, such as neurofilament light chain, myelin oligodendrocyte glycoprotein and myelin basic protein, and neurodegenerative proteins, such as tau and glial fibrillary acidic protein,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Multiple Sclerosis Research Studies
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22252467
DOI: 10.1177/1352458511433303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisPMID 22252467Read ↗

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read ↗

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read ↗

Development of biomarkers in multiple sclerosis.Semantic proximity Read ↗

Neuroimmune proteins can differentiate between tauopathiesSemantic proximity Read ↗

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencingSemantic proximity Read ↗

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesSemantic proximity Read ↗

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionSemantic proximity Read ↗

Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.Semantic proximity Read ↗

Novel plasma and brain proteins that are implicated in multiple sclerosisSemantic proximity Read ↗

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current StatusSemantic proximity Read ↗

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical UseSemantic proximity Read ↗

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.